M&A Deal Summary |
|
|---|---|
| Date | 2019-09-03 |
| Target | Euro Accident |
| Sector | Insurance |
| Buyer(s) | Impilo |
| Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Impilo is a private investment firm focused exclusively on on investments in Nordic companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Impilo prefers majority investments, but will consider select minority situations. Target companies are generally valued between SEK 200 million and SEK 1.5 billion. Impilo has offices in Stockholm and Copenhagen.
| DEAL STATS | # |
|---|---|
| Overall | 6 of 10 |
| Sector: Insurance M&A | 1 of 1 |
| Type: Buyout (LBO, MBO, MBI) M&A Deals | 4 of 8 |
| Country: Sweden M&A | 3 of 4 |
| Year: 2019 M&A | 3 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2019-03-28 |
TFP Fertility
Oxford, United Kingdom TFP Fertility is a provider of IVF and related fertility services with c. 24,000 cycles annually, incl. adjacent services. TFP comprises 19 clinics across the UK, Germany, Austria, Denmark, the Netherlands and Poland, and a sperm bank, a blood lab and c. 80 ultrasound sites across the UK. TFP is based in Oxford, England. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-12-15 |
Mallax Pharmaceuticals
Stockholm, Sweden Mallax Pharmaceuticals is a pharma company ‘ready-to-use’ with required pharmaceutical processes and licenses. Mallax Pharmaceuticals was founded in 2020 and is based in Stockholm, Sweden. |
Buy | - |
